2024
Proceedings from an international consensus meeting on ablation in urogenital diseases
Iezzi R, Contegiacomo A, De Filippis A, Gunn A, Atwell T, Mcclure T, Jing Z, Posa A, Scrofani A, Maresca A, Madoff D, Goldberg S, Kelekis A, Filippiadis D, Sala E, Ahmed M. Proceedings from an international consensus meeting on ablation in urogenital diseases. Insights Into Imaging 2024, 15: 267. PMID: 39514046, PMCID: PMC11549275, DOI: 10.1186/s13244-024-01841-2.Peer-Reviewed Original ResearchInternational Consensus MeetingAblation techniqueIntermediate-risk prostate cancerImage-guided ablation techniquesPreoperative surgical riskManagement of oncological diseasesRenal cell carcinomaConsensus meetingTraditional surgical treatmentGenitourinary tract diseaseFibroid SymptomCell carcinomaProstate cancerSurgical riskAblation therapyImprove patient outcomesTumor managementSurgical treatmentMechanism of actionEffective alternativeTherapeutic alternativeSite of applicationEffective treatmentUrogenital diseasesOncological diseases
2022
Hospital admission risks and ambient fine particulate matter exposure in Beijing, China
Wu Z, Liang F, Chen X, Liu G, Li G, Tian L, Guo Q, Yang C, Zhou Z, Pan X, Liu Y. Hospital admission risks and ambient fine particulate matter exposure in Beijing, China. Atmospheric Environment 2022, 288: 119291. DOI: 10.1016/j.atmosenv.2022.119291.Peer-Reviewed Original ResearchHospital admission riskMalignant tumorsRespiratory diseaseAllergic diseasesUrogenital diseasesPM2.5 exposureMetabolic diseasesMental disordersAdmission riskLong-term exposureAmbient fine particulate matter (PM2.5) exposureFine particulate matter exposureAmbient PM2.5 exposureLong-term PM2.5 exposureParticulate matter exposurePoisson regression modelsAmbient PM2.5 levelsIschemic strokeCirculatory diseasesMatter exposureHA riskAge groupsTumorsDiseaseSubgroup populations
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply